{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360011145386183552.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/jid.1960.55"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022202X15493984?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022202X15493984?httpAccept=text/plain"}}],"dc:title":[{"@value":"Fixed Drug Eruption Caused by 8-Chlorotheophylline in Dramamine® with Clinical and Histologic Studies††From the Division of Dermatology, Department of Medicine, State University of New York, Downstate Medical Center, New York City, New York."}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380011145386183552","@type":"Researcher","foaf:name":[{"@value":"Conrad Stritzler"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011145386183553","@type":"Researcher","foaf:name":[{"@value":"Alfred W. Kopf"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0022202X"}],"prism:publicationName":[{"@value":"Journal of Investigative Dermatology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1960-05","prism:volume":"34","prism:number":"5","prism:startingPage":"319","prism:endingPage":"330"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022202X15493984?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022202X15493984?httpAccept=text/plain"}],"createdAt":"2010-08-17","modifiedAt":"2019-06-02","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282679277344256","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"On Pathogenesis of the Fixed Drug Eruption"},{"@language":"ja","@value":"固定薬疹の発生機序について"},{"@value":"固定薬疹の発生機序について Epidermis affinity antibody(仮称)の提唱(樋口謙太郎教授退官記念特別講演)"},{"@language":"ja-Kana","@value":"コテイヤクシン ノ ハッセイ キジョ ニ ツイテ Epidermis affinity antibody カショウ ノ テイショウ ヒグチケンタロウ キョウジュ タイカン キネン トクベツ コウエン"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/jid.1960.55"},{"@type":"CROSSREF","@value":"10.2336/nishinihonhifu.34.553_references_DOI_JS3AZRH7B4metn1dFKB0pEVOr7X"}]}